๐บ๐ธโก๏ธ โ Warhound, a new Texas-based defense biotechnology startup developed by Colossal Biosciences CEO Ben Lamm and Anduril founder Palmer Luckey, has emerged from stealth with $200 million in seed funding to develop genetically enhanced military working dogs, Fortune writes. Led by former Pentagon chief data officer David Spirk, the company plans to clone proven military dogs and use gene editing to eliminate inherited health conditions and potentially improve performance. Its first dogs have already been genetically sampled, with initial deliveries expected in approximately two years. Anduril will provide protective equipment, body armor and integration with its Eagle Eye system, allowing dogs, handlers and autonomous systems to operate together. The company expects its first puppies by early 2027 and aims to have dogs in service in 2029.